1. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Issue 10359 (8th October 2022) Authors: Mackenzie, Isla S; Hawkey, Christopher J; Ford, Ian; Greenlaw, Nicola; Pigazzani, Filippo; Rogers, Amy; Struthers, Allan D; Begg, Alan G; Wei, Li; Avery, Anthony J; Taggar, Jaspal S; Walker, Andrew; Duce, Suzanne L; Barr, Rebecca J; Dumbleton, Jennifer S; Rooke, Evelien D; Townend, Jonathan N; Ri... Journal: Lancet Issue: Volume 400:Issue 10359(2022) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021) Authors: Abaleke, Eugenia; Abbas, Mustafa; Abbasi, Sadia; Abbott, Alfie; Abdelaziz, Ashraf; Abdelbadiee, Sherif; Abdelfattah, Mohamed; Abdul, Basir; Abdul Rasheed, Althaf; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdulshukkoor, Niyaz; Abdusamad, Kula; Abed El Khaleq, Yazeed; Abedalla, Mai; Abeer Ul A... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Issue 17 (7th March 2022) Authors: Kohli-Lynch, Ciaran N.; Lewsey, James; Boyd, Kathleen A.; French, Dustin D.; Jordan, Neil; Moran, Andrew E.; Sattar, Naveed; Preiss, David; Briggs, Andrew H. Journal: Circulation Issue: Volume 145:Issue 17(2022) Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biochemistry laboratories should routinely report non-HDL-cholesterol. (November 2015) Authors: Preiss, David; Neely, Dermot Journal: Annals of clinical biochemistry Issue: Volume 52:Number 6(2015:Nov.) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Issue 10 (October 2019) Authors: Kristensen, Søren L; Rørth, Rasmus; Jhund, Pardeep S; Docherty, Kieran F; Sattar, Naveed; Preiss, David; Køber, Lars; Petrie, Mark C; McMurray, John J V Journal: Lancet Issue: Volume 7:Issue 10(2019) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Issue 7 (18th August 2020) Authors: Willeit, Peter; Tschiderer, Lena; Allara, Elias; Reuber, Kathrin; Seekircher, Lisa; Gao, Lu; Liao, Ximing; Lonn, Eva; Gerstein, Hertzel C.; Yusuf, Salim; Brouwers, Frank P.; Asselbergs, Folkert W.; van Gilst, Wiek; Anderssen, Sigmund A.; Grobbee, Diederick E.; Kastelein, John J.P.; Visseren, Fran... Journal: Circulation Issue: Volume 142:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004–2013 Europe. (29th August 2020) Authors: Achelrod, Dmitrij; Gray, Alastair; Preiss, David; Mihaylova, Borislava Journal: European journal of preventive cardiology Issue: Volume 24:Number 4(2017) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004–2013 Europe. (March 2017) Authors: Achelrod, Dmitrij; Gray, Alastair; Preiss, David; Mihaylova, Borislava Journal: European journal of preventive cardiology Issue: Volume 24:Number 4(2017) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗